It is a trading private limited company based in New Delhi, Delhi, India, established in 2015.
2015 | New Delhi, Delhi, India | ActiveScinder Pharmaceuticals Private Limited, a active private limited company, was established on 23 June 2015 in New Delhi, Delhi, India. Engaging in wholesale within the trade sector, it holds CIN: U51101DL2015PTC281891. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Mahak Ruhela (Director), Nitesh Rohilla (Director). Past directors included Mahak Ruhela, Kaleem Ahmad. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 9-A, Shivpuri Road Shivpuri Extension, New Delhi, Delhi, 110051.
U51101DL2015PTC281891
281891
23 June 2015
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Scinder Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mahak Ruhela | Director | 18 Sep 2020 | Current |
| Nitesh Rohilla | Director | 23 Jun 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 21 Sep 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Scinder Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Scinder Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Scinder Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Scinder Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scinder Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Scinder Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
Progress on Scinder Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi. was documented.
Mahak Ruhela was appointed as a Director was appointed as a Director on 18 Sep 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.
Progress on Nitesh Rohilla was appointed as a Director was appointed as a Director on 23 Jun 2015 & has been associated with this company since 10 years 5 months . was documented.
Progress on Scinder Pharmaceuticals Private Limited was registered on 23 Jun 2015 with Roc Delhi & aged 10 years 5 months as per MCA records. was documented.
The CIN of Scinder Pharmaceuticals Private Limited is U51101DL2015PTC281891.
Scinder Pharmaceuticals Private Limited is headquartered at 9-A, Shivpuri Road Shivpuri Extension, New Delhi, Delhi, 110051.
Scinder Pharmaceuticals Private Limited was incorporated on 23 June 2015.
The current directors of Scinder Pharmaceuticals Private Limited are
The primary industry of Scinder Pharmaceuticals Private Limited is Trade.
Scinder Pharmaceuticals Private Limited is unlisted.
The authorized capital of Scinder Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Scinder Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX